November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Myeloma Paper of the Day, July 8th, suggested by Robert Orlowski
Jul 8, 2024, 12:29

Myeloma Paper of the Day, July 8th, suggested by Robert Orlowski

Robert Orlowski shared on X:

Myeloma Paper of the Day: Analysis of Canadian Myeloma Research Group Database finds tandem autologous transplantation (vs. 1 ASCT) does not benefit high-risk myeloma patients (overall and in subgroups) in the maintenance era on either PFS or OS.

Source: Robert Orlowski/X

Tandem Autologous Stem Cell Transplantation Does Not Benefit High-Risk Myeloma Patients In The Maintenance Era: Real-world Results From The Canadian Myeloma Research Group Database

Authors: Christopher P Venner, Peter Duggan, Kevin Song, Donna Reece, Smriti Sharma, Jiandong Su, Victor H Jimenez-Zepeda, Arleigh McCurdy, Martha Louzada, Hira Mian, Michael Sebag, Darrell White, Julie Stakiw, Rami Kotb, Muhammad Aslam, Anthony Reiman, Engin Gul, Michael P Chu, Debra Bergstrom and Richard LeBlanc.

Myeloma Paper of the Day, July 8th, suggested by Robert Orlowski

Other posts featuring Robert Orlowski on OncoDaily.

Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.

Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.